Based on our knowledge, our work represents the first comprehensive study of SLE patients, and we revealed that elevated serum sTfR levels are associated with an increased risk of cardiovascular, pulmonary, and haematological manifestations, and a decreased risk of neuropsychiatric manifestations. The gene discussed is TFRC; the disease is systemic lupus erythematosus.